Glaxo To Pay $1B To Settle Paxil Birth Defect Cases

July 22, 2010

Add Us On Google

Related

Charles River reports lower Q4 2025 revenue in struggling CDMO business

Charles River reports lower Q4 2025 revenue in struggling CDMO business

Fujifilm doubles quality control footprint at Danish commercial-scale manufacturing site

Fujifilm doubles quality control footprint at Danish commercial-scale manufacturing site

2026 Manufacturing Pharma Trends for Life Sciences

Sponsored

2026 Manufacturing Pharma Trends for Life Sciences

2026 AI Trends in Life Sciences

Sponsored

2026 AI Trends in Life Sciences

Trending

Lilly adds $4.5B to Indiana sites, opens first dedicated genetic medicine facility

Japanese pharma companies engage CDMOs earlier in development: Neuland Labs

Amgen adds $300M investment to biologics manufacturing facility in Puerto Rico

Sponsored Picks

Sponsored

An Advanced Way to Install a Compressed Air System

Sponsored

The Battle in Your Pipes: Gravity vs Air Velocity in Condensate Mgmt

Sponsored

Condensate Management in Your Compressed Air System